Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum
Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum
复制标题
DOI:
10.1016/j.trstmh.2005.04.021
复制
发表时间:
2006-02-01
影响因子:
2.2
通讯作者:
Babiker, HA
中科院分区:
文献类型:
--
作者:
Ali, E;Mackinnon, MJ;Babiker, HA
We monitored post-treatment Plasmodium falciparum among patients treated with chloroquine (CQ) and sutfadoxine-pyrimethamine (SP; Fansidar(R)) in a village in eastern Sudan. Parasites were examined on day 0 (pre-treatment), day 7, day 14 and day 21 (post-treatment) during the transmission season. A further sample was taken 2 months later (day 80) at the start of the dry season. Asexual forms and gametocytes were detected by microscopy, and reverse transcriptase polymerase chain reaction (RT-PCR) was used to detect expression of gametocyte-specific proteins pfs25 and pfg377. Gametocyte carriage, as revealed by microscopy, increased significantly following CQ and SP treatment, reaching a maximum between days 7 and 14. When measured by RT-PCR, however, there was no significant difference in gametocyte rate between day 0 and days 7 or 14. RT-PCR gametocyte rates dropped dramatically by day 80 post treatment but were still 33% and 8% in the CQ- and SP-treated group at this time. Alleles associated with drug resistance of P falciparum to chloroquine (the chloroquine resistance transporter, pfcrt, and multidrug resistance, pfmdr1) and to pyrimethamine (dihydrofolate reductase, dhfr) were seen at a high frequency at the beginning of treatment and increased further through time following both drug treatments. Infections with drug-resistant parasites tended to have higher gametocyte prevalence than drug-sensitive infections. (C) 2005 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.